Maprelin, which contains a new active molecule, Peforelin, is a gonadotropin releasing hormone (GnRH). A single, low volume injection of the ready-to-use solution induces oestrus in sows after weaning, and in sexually mature gilts where oestrus has been synchronised with Regumate Porcine.
According to the company, it works by selectively inducing the release of the animal's own follicle stimulating hormone (FSH), leading to follicle growth - critical to successful reproduction - and the stimulation of oestrus. Conventional GnRHs, because of their mode of action, are used mainly to induce ovulation.
Janssen says Maprelin is the next step in its pig reproduction programme, named Syncoris. Cornerstone of this programme is Regumate for gilt synchronisation.
Trials have shown that with the use of Maprelin (compared with control groups of breeding animals) the number of gilts and sows showing oestrus within six days of treatment increased by about 15 percentage points (Table 1). For first-litter sows the figure was more than 8 percentage points. The duration of oestrus was not affected.
Gilts came on heat two days faster than with Regumate alone, and the weaning to oestrus interval with sows achieved similar statistically significant reductions.
Farrowing rate increased by over 5 per cent for sows, by 6 per cent for first-litter sows and just on 8 per cent for gilts.
Added to those benefits, for each 100 inseminations sows produced an extra 104 piglets, first-litter sows 105 and gilts an even more impressive 158. All gilt groups in the trials, including the control groups, were synchronised with Regumate. With unsynchronised gilts it is not possible to predict the correct time to inject Maprelin.
Phil Macdonald, the company's UK pig and poultry business manager, says the objective of every producer is profitable pigmeat production. "In the UK and other EU states the costs of feed, housing and labour are considerably higher than in other major pig-producing sectors of the world.
"This makes it important for UK producers to optimise management of the reproductive process. Maprelin is a valuable tool that can help with this objective."
The precision injection gun with Maprelin enables accurate delivery of the small amounts required. Gilts require a 2.0 ml dose 48 hours after their last Regumate treatment, first-litter sows a 0.5 ml dose 24 hours after weaning and multi-litter sows 2.0 ml 24 hours after weaning. Injections are intramuscular.
The solution requires no mixing, reducing the possibility for errors. Opened vials have a shelf life of 28 days and unopened vials a shelf life of two years. Sows and gilts need only one injection per parity, and the withdrawal period for meat and offal is zero days.
The one-day event, called VetQuest, will allow prospective students to spend the day being mentored by a current student whilst getting involved in interactive sessions, such as large animal skills, clinical skills and veterinary public health.
Participants will learn about the opportunities available to those interested in pursuing a veterinary career, have a tour of the school and attend talks on vet admissions and work experience.
Dr Louisa Slingsby, Teaching Fellow and Faculty Admissions and Recruitment Officer at the Bristol Vet School, said: "VetQuest allows those who are interested in a career in the veterinary professions to come along for a day to find out more about the roles of veterinary surgeons and veterinary nurses.
"They will also have the opportunity to learn what to think about when choosing and applying for courses and how to give themselves the best possible chance to make an informed decision about if vet medicine is the career for them."
There will also be an optional session for parents and carers to help them navigate the challenges of applying to study to be a vet or vet nurse. The morning starts with a tour and then a talk and a Q&A session and finishes around lunchtime.
The cost of the one-day event is £50 and there are a limited number of subsidised places at £10. Lunch is included in the registration fee. To book visit https://www.bristol.ac.uk/vetscience/events/2018/vetquest-2018.html.
The event is primarily aimed at years 11 and 12, although anyone is welcome to attend.
For further information about VetQuest, email: svs-vetquest@bristol.ac.uk or tel: +44 (0)117 928 9280.
1,300 veterinary surgeons responded to the BVA survey, which was carried out in July. They were asked what Official Controls Qualification (OCQ) they hold or have held in the past, and give reasons for dropping a previously held qualification or choosing not to revalidate.
According to the BVA, many respondents criticised the current training and revalidation process, which is administered by Improve International on behalf of the Animal and Plant Health Agency (APHA).
Factors including time, the cumulative cost of renewing each module at regular intervals, a lack of relevance and duplication of learning across different modules were all cited as reasons for choosing to drop qualifications.
25% of vets who currently hold the Essential Skills OCQ say they are planning not to renew the qualification, with 67% saying it is because of the expiry of grandfather rights and 66% saying it is because they find the requirements too onerous.
18% of those who currently hold the Tuberculin Testing OCQ are not planning on renewing, either because they are finding the revalidation requirements too onerous (58%), too expensive (42%) or because the work is not sufficiently rewarding (42%).
35% of those who hold the Statutory Surveillance OCQ are not planning on renewing, primarily because of overly onerous revalidation requirements.
The largest drop off is predicted amongst holders of the Exports OCQ, 38.4% of whom said they plan not to revalidate.
Amongst the species bolt-ons, 45.5% of the holders of the Small Animal Exports OCQ, 51% of the Ungulate Exports OCQ, 66% of the Equine Exports OCQ, 72.5% of the Avian Exports OCQ, 47% of the Product Exports OCQ, 68% of the Germinal Products Exports OCQ and 32% of the Companion Animals OCQ said they plan not to renew, either because of the expiry of grandfather rights, or the expense or, in the case of Ungulate Exports, because revalidation is too onerous.
In the current system equine exports are included in the ungulate export OCQ, which the BVA says was a concern for those vets who only work with farm animals. APHA and Improve International have helpfully introduced an equine-only OCQ for exports that better meets the needs of equine-only vets.
BVA reports that it has had a positive meeting with APHA to discuss the survey results and explore practical solutions to iron out issues with the current system and make it easier to use. As a next step, BVA has agreed to review the modules and make recommendations for improving the structure of training and the revalidation process.
BVA President John Fishwick said: "The unprecedented response rate to this survey really hits home the strength of feeling on this issue. There is an urgent need to review and improve the revalidation process to safeguard against capacity and capability issues in this critical section of the workforce.
"It’s really positive that APHA recognises that there are issues with the current system and is keen to work with us to make it more proportionate and fit for purpose while continuing to maintain high standards. It’s more important than ever to retain skilled professionals so that the workforce is at full strength to respond robustly to disease outbreaks and meet demand for export certification after Brexit."
Andrew Soldan, APHA Veterinary Director said: "The integrity of our official controls and export certification is vitally important. The Official Controls Qualifications are a key part of this as they provide standardised OV training as well as assurance of high standards. I’m grateful to BVA for their assistance as we look to make further improvements to the system in the future."
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Reference
It's believed that VetSurgeon.org and VetNurse.co.uk, which run on a platform that predates Facebook, may be the first online communities to require good manners.
Under the new policy, anyone who posts anything in the forums which is sarcastic, belittling, snide, rude or unkind towards another member will face immediate removal from the website.
This marks a very radical change to the previous policy in which members were free to say pretty much what they wanted.
VetSurgeon.org Publisher Arlo Guthrie said: "For years, I felt the right to free speech trumped all, and would rarely intervene.
"When I did, the worst anyone faced was a temporary suspension.
"As time has passed, I've realised the limitations of the written word, especially the short-form, hastily-written word, which can cause real distress.
"We all moderate our language offline, it's just a question of realising that we need a different set of standards online, to account for the lack of facial expression and immediacy of reply, and the public nature of the discussion.
Some people have questioned the new policy, and whether it will stifle proper debate.
Arlo added: "I believe not. It is perfectly possible and OK to disagree with someone, and express that disagreement forcefully, without being sarcastic.
"On the contrary, I think that allowing bad manners has a far more chilling effect on free speech, because it scares off opinions from the majority of more moderate members"
Others have asked whether this new policy is the consequence of the new partnership with Improve International, or proposed new laws surrounding social media.
Arlo said: "Again, no. It was a very personal decision I reached after years of wrestling with the problem. It was precipitated by a series of unkind posts and I just thought 'enough's enough'.
"That said, I am really excited about the prospect of working with Improve to grow the community as somewhere its members can come for high quality clinical content and authoritative opinion, which for sure would be hard to achieve if we don't have a friendly, collaborative atmosphere."
Another issue raised about zero tolerance is whether it is fair that there may be no second chance.
Arlo said: "I've tried loads of things over the years. Warnings. Red cards. Suspensions. None of them work. People just push the boundaries.
"But the moment I said 'zero tolerance', it seems people get the message and moderate themselves accordingly."
"I'm delighted. I want people to think of VetSurgeon.org as somewhere everyone can come for authoritative advice and support, confident of a friendly welcome and the highest standards of online behaviour."
The RCVS Disciplinary Committee has dismissed charges of serious professional misconduct against a veterinary surgeon and former employee of Medivet (Watford).
Tomasz Nazimek, who qualified in Poland in 2001 before starting work in England in 2005, was alleged to have charged for the use of a blood pressure monitor during an exploratory laparotomy on a cat called Mitzi, whilst working at the Watford branch of Medivet in June 2009, when he knew, or ought to have known, it had not been used.
Despite his previous signed statements to the contrary, Mr Nazimek admitted at the outset of the hearing that no blood pressure monitor had in fact been used.
Accordingly, the Committee only had to establish whether Mr Nazimek himself had entered the fee for its use into Mitzi's records and, if so, whether this was done dishonestly.
The alleged incident came to light as a result of a covert investigation into Medivet conducted by the television production company Fulcrum TV in 2008/9, and subsequently commissioned by the BBC and broadcast in July 2010 as part of the Panorama programme 'It Shouldn't Happen at a Vets''.
Former dental nurse Alexandra Lee was employed by Fulcrum TV as an undercover reporter to work as a 'trainee veterinary nurse' at Medivet, in order to record audio and video footage of her experiences there.
The case against Mr Nazimek was based partly on a conversation overheard by Miss Lee following the operation on Mitzi, where she maintained that Guy Carter, a senior Medivet partner and veterinary surgeon, told Mr Nazimek (who was sitting at the practice computer typing up Mitzi's records) not to forget to include a fee for use of the blood pressure monitor.
However, Miss Lee's equipment had not recorded this exchange, due to a fault, and her video diary of that day's events was not put in evidence before the Committee. Miss Lee also accepted in evidence that she had not actually seen who entered the fee into the records, but had assumed it was Mr Nazimek.
Despite giving serious consideration to all of Miss Lee's evidence, the Committee found it of limited value.
The Committee considered the statements signed by Mr Nazimek, but prepared for him by the Medivet senior management in December 2009 and October 2010, which stated that he had used the monitor, consulted Mr Carter about charging for it and then added the fee himself.
The Committee also considered a third statement provided to the College (September 2011), in which Mr Nazimek recalled that Mr Carter had priced up the operation himself, but not asked for his input.
When questioned about the discrepancies in his statements, Mr Nazimek told the Committee that he had confused different operations and now knew his earlier statements to be wrong.
He indicated that he had been under pressure from his then employers to sign the statements, that his attempts to change them were ignored by Medivet's managing partners and that he was depressed and under stress at the time.
He was not told that the statements could be in relation to charges against him, or that he was entitled to legal advice when discussing them with his employers.
The Committee found Mr Nazimek's oral evidence to be persuasive, his manner open and his responses under cross-examination frank.
In the absence of satisfactory and reliable evidence to the contrary, and in view of supportive testimonials provided from his current employer and former colleagues as to his honesty and integrity, the Committee found Mr Nazimek's repeated assertion that he did not make a charge for the monitor "entirely plausible" and believed that he told the truth.
Nevertheless, the Committee emphasised that a charge for the monitor had been entered into the records when no such device had been used, which it regarded as unacceptable.
Speaking on behalf of the Committee, Chairman Professor Peter Lees said: "The Committee is not satisfied by the evidence so that it is sure that [Mr Nazimek] entered into the records for Mitzi a charge for the blood pressure monitor. [It] believes that [Mr Nazimek] told the truth when giving his evidence and the character references support his honesty.
"In these circumstances, it is not necessary to consider the charges further and the allegations against [Mr Nazimek] are dismissed."
The study, titled “The utility of combined urine dipstick analysis and specific gravity measurement to determine feline proteinuria”, assessed the utility of the urine dipstick alone and combined with the urine-specific gravity (USG) for detecting proteinuria in cats.
For the study, the clinical records of cats presenting to a referral hospital between January 2011 and January 2017 were reviewed retrospectively.
To be eligible for inclusion, feline urine samples had to have undergone a complete urinalysis including dipstick evaluation, USG and urine protein-to-creatinine (UPC) measurement.
A total of 121 urine samples were included and diagnostic agreement and test accuracy were calculated for the dipstick test alone and in combination with the USG, using different cut-off values for proteinuria. Receiver-operating characteristic (ROC) curves were also calculated.
Jorge Pérez-Accino, corresponding author for the paper, said: “The diagnostic agreement between the urine dipstick and UPC ratio was poor and did not improve if the USG was considered together with the dipstick.
"A dipstick result of equal or greater than “Trace” (0.1-0.3g/L) had a sensitivity of 81% and a specificity of 31% to detect proteinuria.
"With regards the ROC curves, the area under the curve (AUC) of the urine dipstick alone was poor (0.57). When combined with the USG results, this improved to fair (0.78) but the specificity and negative predictive value (NPV) were still low.”
Nicola Di Girolamo, Editor of JSAP said: “These findings indicate that clinicians should not rely on the results of the urine dipstick test in combination with USG in cats for detecting proteinuria. Instead other quantitative methods, such as UPC ratio, should always be performed to detect proteinuria in cats.”
The full article can be found in the September issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13184
The BSAVA has put together a collection of resources relating to urinalysis and proteinuria, available here: https://www.bsavalibrary.com/content/urinalysis--160
Bayer Animal Health has taken over the marketing and sales of the antibiotic Nisamox (tablets containing Amoxicillin and Clavulanic Acid), from Fort Dodge Animal Health.
Under the new arrangement, the design of Nisamox tablet packaging will change to reflect the change of ownership, however, Bayer says the quality of the tablets and the competitive pricing remain unchanged.
Nisamox tablets are licensed for use in cats and dogs to treat infections of the skin, urinary tract, and respiratory tract caused by susceptible Staphylococci, and also to treat enteritis and urinary tract infections caused by susceptible E.coli.
Nisamox tablets will continue to be available in three strengths: 50mg, 250mg, and 500mg. For information on Nisamox tablets, contact your Bayer territory manager.
The CPD event is in two parts. The first is a webinar on Tuesday 30th April at 7:30pm by Dr Jo Murrell DipECVAA (pictured right) entitled: Analgesia for ovariohysterectomy in dogs and cats and the role of Comfortan.
Jo will present the results of studies she has conducted to investigate which opioid provides optimum analgesia for the procedure in both dogs and cats. In one study, she compared the analgesic effect of peri-operative methadone with peri-operative buprenorphine in dogs. In the other, she compared the analgesic effects of methadone with buprenorphine in cats undergoing ovariohysterectomy using the QUAD anaesthetic protocol.
You can register now for Dechra’s webinar, here.
The webinar will be followed by the opportunity to put follow-up questions to Jo in a special forum in the new Anaesthesia group on VetSurgeon.org, where she has become a VetSurgeon Contributing Expert.
The webinar entitles you to one hour of CPD, which you can supplement with any additional time spent discussing the issue with Jo in the forum, using the ‘Claim CPD’ button.
The event also marks the official launch of the new Small Animal Anaesthesia Group on VetSurgeon.org, and I would like to invite all members of VetSurgeon.org with an interest in anaesthesia to come and join the group here (press the ‘Join’ button on the left hand side; you may need to rotate your mobile phone to see it).
In addition, you may wish to subscribe to the digest which will alert you to any new anaesthesia discussions on a daily or weekly basis, as you prefer.
Eprecis injection (eprinomectin) is an broad spectrum endectocide with activity against gastrointestinal nematodes in sheep1 and goats2.
After Eprecis injection Haemonchus contortus in the abomasum in goats were reduced by 97.8%2 and Trichostrongylus colubriformis in the small intestine were reduced by 98.7%2.
In lactating dairy ewes Eprecis injection was found to be 99% effective against gastrointestinal nematodes3 and was associated with an increased milk yield of 8%4.
The bioavailability of eprinomectin after one Eprecis injection in goats is larger than that reported for eprinomectin pour on5, 6, with Eprecis injection found to be four times more efficacious than eprinomectin pour-on across four dairy goat farms7.
In sheep, the efficacy of Eprecis injection against gastrointestinal nematodes in sheep is 99.6% versus 86.1% for a pour-on formulation8.
Eprecis injection is associated with higher plasma levels of eprinomectin and has a higher efficacy compared to eprinomectin pour-on in dairy ewes naturally infected with gastrointestinal nematodes8.
This is also achieved using five times less active than a pour-on formulation8.
Eprecis injection is administered subcutaneously and there is no need to part the fleece or coat along the animal’s back.
Ceva says it has excellent syringeability9 and a low dose volume (0.1ml/10kg) to help with accurate dosing of animals.
Harry Walby, ruminant veterinary advisor at Ceva Animal Health, said: “Eprecis injection is a highly effective broad-spectrum wormer that is now available in sheep and goats, as well as cattle.
"The injectable formulation not only allows accurate dosing, but there is no subclinical dose transfer between animals.”
Eprecis injection is available in 100ml and 250ml CLAS vials.
References
Zoetis has launched a 4ml vial of the antibiotic, Convenia.
Zoetis says Convenia gives veterinary surgeons control by providing an assured injectable treatment course, relieving clients of the burden of daily dosing. This avoids missed or mistimed doses, lost tablets, or courses stopped too soon, thereby eliminating a major reason for treatment failure, non-compliance. Poor compliance is also a significant factor in the development of antimicrobial resistance.
Convenia is licensed for skin, soft tissue and urinary tract infections in dogs and cats, as well as severe gingivitis/periodontitis in dogs (as an adjunct to mechanical or surgical periodontal therapy). A 4ml vial can treat up to 40kg of bodyweight, making it appropriate for treating cats and smaller dogs.
Zoetis says that the launch of the new vial demonstrates its commitment to the 'Respect Antibiotics' campaign launched last year. The Respect Antibiotics campaign encourages careful and informed selection of appropriate antibiotic therapies for the treatment of dogs and cats.
Product Manager, Andrew Page, said; "We are committed to encouraging responsible antibiotic usage, and reducing the incidence of antibiotic resistance. Non-compliance plays a key role in the development of antibiotic resistance and we hope that by making Convenia more accessible through the introduction of a 4ml vial we can help alleviate compliance issues."
For further details about Convenia please contact your Zoetis Account Manager.
The authors say that an association between acute kidney injury and general anaesthesia is well-defined in human medicine, but there is little information in the veterinary literature.
In their new study, called “Twelve previously healthy non-geriatric dogs present for acute kidney injury after general anaesthesia for non-emergency surgical procedures in the UK1”, Emma Rogers-Smith and her co-authors retrospectively analysed the medical records of 12 dogs that presented for acute kidney injury following general anaesthesia across three multidisciplinary referral centres and one primary care practice in the UK. Information obtained included signalment, general anaesthesia, surgical procedure and peri-surgical management.
The aim was to characterise common factors after a suspected increase in incidence of post-procedure acute kidney injury in animals without identifiable risk factors.
Emma Rogers-Smith, a resident in internal medicine at Davies Veterinary Specialists and corresponding author for the paper, said: “A suspicion that there was an increase in non-geriatric dogs suffering acute kidney injury (AKI) shortly after elective procedures led to this study.
"Whilst our data supported this suspicion, there was an increase in incidence, the change itself is not statistically significant and so we are unable to be conclusive.
"This study is limited by small sample size and retrospective nature of the data. At this time no definitive causal link between these cases has been found.
"As such, we are urging clinicians with similar experiences in the last 24 months to get in touch. We hope to ascertain if there is any commonality between these cases and, if possible, better define the incidence of AKI in non-geriatric animals following elective procedures.”
Nick Jeffery, editor of JSAP said: “Nowadays, most veterinarians consider general anaesthesia safe in dogs and routinely allay pet-owner concerns. Whilst AKI following general anaesthesia seems to be rare, it is worrying that a specific risk factor was not identified in any dog, despite a wealth of available clinical data. I would urge any veterinarians that have similar cases to contact the authors.”
Any clinicians with similar experiences during the last 24 months should contact Emma Rogers-Smith on emma.rogers-smith@vetspecialists.co.uk.
The full article can be found in the June issue of the Journal of Small Animal Practice, and here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13134
Vets Now is expanding its referral service with the acquisition of Great Western Referrals, a referral hospital in Swindon.
The acquisition is Vets Now Referrals' second permanent site to complement its original referral service in Glasgow and its first operation in England, allowing it to extend its specialised veterinary services across the South West.
Vets Now Referrals says it plans to enhance its new acquisition by improving the premises and extending the current referral team, beginning with the appointment of a new orthopaedic surgeon who will support the current RCVS and European Specialist in Veterinary Surgery: Hannes Bergmann DrVetMed DipECVS MRCVS.
As part of the acquisition, Great Western Referrals will be renamed Vets Now Referrals. It will offer a full small animal referral service with specialists trained in Surgery (Orthopaedics, Soft-Tissue, Spinal), Internal Medicine, Dermatology, Cardiology, Diagnostic Imaging, as well as Avian and Exotic Medicine. In addition, an independent out of hours emergency service will also be available from Vets Now at the hospital for all member practices in the area.
Vets Now Referrals will incorporate the specialist care currently offered for exotic pets, Great Western Exotic Vets. This service will continue to be run as Great Western Exotics and will retain the expertise of Neil A Forbes BVEtMed DipECZM(avian) FRCVS, an RCVS and European Recognised Specialist in Avian Medicine.
Richard Dixon, Founder of Vets Now Ltd said: "We are very excited to be extending our Referrals network and will be working hard with the local referring practices and their clients in the surrounding area. We want the local practices to have a strong and genuine say in how the business operates, and some of the early changes already planned have come from discussions with those practices."
"We have been hugely impressed by the exceptional levels of clinical experience within the existing team at Great Western Referrals, as well as their energy and commitment to deliver the best level of specialist care to pets. We will be building on this team and tailoring the service to individual practice needs. Through our acquisition we will also bring resources to help the service grow, bringing added security to the clinical team in Swindon."
"In addition to the referral service, we are very pleased that Vets Now will be operating its highly regarded and well established out of hours emergency service, which we believe will continue to benefit local member practices and their clients."
For further information about the service, visit www.vetsnowreferrals.com/ or call 01793 603 800.
Richard Dixon and Neil Forbes announce Vets Now's acquisition of Great Western Referrals.
Zoetis has announced the launch of Simparica, a once-monthly oral medication for the treatment of flea, tick and mite infestations in dogs beginning at eight weeks of age.
The company says the new product, which comes in the form of a tasty chewable tablet, acts quickly and provides continuous protection for 35 days without losing efficacy at the end of the month.
Simparica is effective against both Ctenocephalides felis and Ctenocephalides canis flea infestations in dogs.² It starts to kill fleas quickly within three hours³ and continues to kill fleas for at least 35 days², making it suitable as part of a treatment strategy for Flea Allergic Dermatitis.
The product also protects dogs against infestations with the most common ticks found to infest dogs in Europe2,4, including Dermacentor reticulatus, the species associated with the disease babesiosis, which has recently been reported in the UK. It’s also the only treatment for Ixodes hexagonus, one of the most prevalent ticks in the UK. The killing effect against Ixodes ricinus starts within 8 hours after a single oral administration and over 96% are killed within 24 hours.4
Zoetis says Simparica is also effective against Rhipicephalus sanguineus, and Sarcoptes scabiei, and that laboratory evidence shows efficacy for Demodex Canis and Otodectes Cynotis.
Zoetis believes that Simparica’s ability to provide continuous protection up to and beyond the monthly treatment period is very important for pet owners. Sixty three per cent of owners confess to giving flea and tick treatment later than when it was due, with the median being 5 days late.¹ Simparica gives vets and forgetful pet owners the peace of mind of extended duration of activity helping to minimise the potential risk of protection gaps.
Ned Flaxman, companion animal business unit director at Zoetis said: "With Simparica, we bring to the market an advanced parasiticide solution, helping to deliver improved client and pet owner satisfaction. The chewable tablets are easy to administer and readily accepted by dogs. But more importantly, Simparica helps vets and dog owners minimise the potential risk of protection gaps, as it acts very fast to kill fleas and ticks and performs for at least 35 days without losing efficacy — well beyond the monthly treatment period.
"With its rapid onset, robust duration of activity and very good safety profile, Simparica is the only oral isoxazoline indicated for four species of ticks in Europe including Ixodes hexagonus and the two species of fleas, dogs are most frequently infested with. Unlike most treatments, Simparica protects from both types of ectoparasites for the same duration."
For more information please speak to your account manager or contact customer support on 0854 300 8034.
Zesti comprises three ranges:
The Spirit range is a more standard looking scrub, manufactured from Alsi-Flex. The ‘Mode’ range looks a little more figure hugging, with an exclusive colour palette, and the Power range has a more sporting look.
Greg Houlston, General Manager, said: “Our healthcare workers need clothing that is practical and comfortable above anything else, yet our market research showed us that when it comes to scrubs with stretch, choice is limited in the UK compared with other markets such as the US.
“Veterinarians in particular need workwear that is especially hard wearing as the nature of their work means their clothing can be especially susceptible to rips, tears and soiling.
“We set out to create a brand that answered the need for more flexibility while challenging the perception that workwear should be dull and boring, and Zesti was born – a vibrant and contemporary range of garments, sustainably designed, to inspire confidence and positivity.”
Sara Catanzaro, Design Manager, added: “Our tailored garments offer exceptional attention to detail while being strong, hard wearing and resilient.
"They can be laundered domestically or industrially up to 60 degrees which is ideal for infection control.
"We’re already witnessing considerable demand as we believe we’ve hit the perfect balance between function and fashion.”
For more information, visit www.zesti.co.uk
The paper details the current and potential uses of this rapidly developing technology, and its benefits and risks.
It provides an introduction to AI and its uses in human medicine, small animal, farm and equine practice, radiology and veterinary education.
It also looks at the potential impact on the wellbeing and working life of veterinary teams.
Results from VetCT’s recent survey on the opinions of AI within the veterinary profession are included in the paper.
Julien Labruyère, Chief Innovation Officer at VetCT, said: “This is a crucial moment in the veterinary industry to ensure we have the knowledge and safeguards in place to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"This white paper aims to provide a firm foundation for understanding AI and stimulate discussion on how it may impact both people and animals.”
The paper also calls for the development of industry-wide guidance, standards and regulations to safeguard veterinary teams and animal health and welfare as these tools are deployed.
Julien added: “AI development is accelerating rapidly, with global governments and industries racing to regulate to ensure the benefits outweigh the potential negative impacts of this far-reaching technology.
"It’s vital that opinion leaders, organisations and regulators from across the veterinary world come together and develop guardrails so we can have confidence that AI tools will benefit our teams and our patients.”
https://5345458.hs-sites.com/vetct-ai-white-paper
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
As part of the new arrangement, Battersea will give StreetVet operational and logistical support, including advice from its staff, clinical support, and kennel space for animals in urgent need of care.
Battersea also plans to work with StreetVet on a range of projects that will help the charity to reach more dogs in need. For example, providing advice and training to hostel staff to promote and facilitate hostels accepting dogs – creating more safe places to sleep for both dogs and their owners.
Battersea’s Deputy Chief Executive, Peter Laurie, said: "I’m excited at the prospect of Battersea and StreetVet coming together for a partnership that aligns both organisations’ strategic values. Both of us care deeply about the welfare of dogs, particularly those most in need. StreetVet relies almost entirely on the support of a growing network of volunteers, including members of the Battersea clinic team, and is a great example of a volunteer-led organisation delivering significant impact on a wide geographical scale. By working together, we can increase our collective impact and help more animals in need."
Sam Joseph MRCVS, a co-founder of StreetVet, said: "We are really excited about the official partnership between StreetVet and Battersea. As a small, growing charity, StreetVet will hugely benefit from the expertise, infrastructure and resources of one of the country's most loved and respected animal charities."
He added: "This partnership will help StreetVet continue to provide free, accessible veterinary care to those most in need, while further increasing the impact that Battersea has on the welfare of dogs and cats across the UK."
Photo: L-R Peter Laurie (Battersea), Jade Statt and Sam Joseph (StreetVet), Shaun Opperman (Battersea) and Blue the Staffie
At the beginning of the hearing legal applications were made to rule that the whole proceedings should be stopped as an abuse of process on various grounds including the delay that had occurred in the matters being referred to the RCVS, and that there had been flaws in the original investigatory process.
There was also application that the evidence of one of the College’s witnesses should be excluded on the grounds that the witness had been convicted of bribery.
The Committee decided that the proceedings should continue but ruled that the statement and evidence of one witness should be excluded from the hearing based upon their conviction.
Mr Gracey faced five charges, all of which he was found guilty of. They were:
Three other charges were found not proven and one allegation was withdrawn by the RCVS.
The Committee then considered if the proven charges amounted to serious professional misconduct.
In doing so it made reference to the Code of Professional Conduct and its supporting guidance, particularly in relation to the 10 Principles of Certification.
Dr Hazel Bentall MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee considered individually and cumulatively all matters it had found proved.
"It concluded that the public relies on veterinary surgeons to be honest and transparent when completing and signing forms.
"There is a public interest in being able to trust the profession to uphold high standards of probity because veterinary surgeons are trusted to play an important role in the promotion of animal health and welfare and associated human health.
"The Committee therefore concluded that cumulatively Charges 1, 2, 3 and 4 amounted to serious professional misconduct because the respondent had failed to meet the necessary high standards of honesty and transparency.
"In particular the fact that there were four separate events relating to animal welfare and public health was significant when considering what sanction to impose.”
“The Committee is satisfied that such conduct, when taken together, would be considered deplorable by other members of the profession.
"The respondent’s conduct on four occasions in respect of four animals and three conflicts of interest called into question his competence in relation to completing such forms.”
In considering the appropriate sanction for Mr Gracey, the Committee took into account both mitigating and aggravating circumstances, as well as a number of character witnesses for the respondent who highlighted his positive personal and professional qualities.
In mitigation, the Committee considered that Mr Gracey has hitherto been of good character with no previous disciplinary findings, that he had admitted some parts of the charges against him at the outset of the hearing, that he had made efforts to avoid repeating the misconduct and remediate it – this included making alternative certification arrangements for his father’s farm and taking more appropriate care with record keeping.
The Committee also acknowledged the significant lapse of time between the date of the misconduct and the hearing and the stress that had caused to Mr Gracey, as well as the insight he had shown into his misconduct.
Taking into account all the factors, the Committee decided that imposing a period of six months suspension from the Register of Veterinary Surgeons was the appropriate sanction for Mr Gracey.
Dr Bentall added: “The Committee concluded that suspension of the respondent’s registration for a period of six months was proportionate.
"The Committee considered whether a shorter period was appropriate bearing in mind the mitigating factors it had found applied in this case.
"It decided that a period of six months was proportionate and the minimum length necessary to meet the public interest balancing the seriousness of the misconduct and the mitigation.
"It decided that a shorter period of suspension would be insufficient to uphold proper standards within the profession, or to have a deterrent effect.
“The Committee was satisfied that the respondent had shown sufficient insight and efforts to remediate his misconduct and it concluded that at the end of this period of suspension he would not pose a further risk to animal welfare or public health.
"The Committee considered that the respondent was a valued veterinary surgeon with extensive farm animal experience and that a more severe sanction such as removal from the RCVS Register would not properly reflect the Committee’s findings on the scale of dishonesty and would not take account of the respondent’s mitigation.”
www.rcvs.org.uk/disciplinary
The Cat Friendly Veterinary Professional course is aimed at veterinary surgeons and nurses and covers all aspects of being cat friendly over six modules, including understanding where cats come from, their behaviours, stress free handling, how to be more cat friendly in practice and client communication.
The four-module Cat Friendly Veterinary Receptionist course is aimed at receptionists and includes everything a receptionist needs to know about cats and how to be cat friendly, including their role in making the practice cat friendly.
Both are 3 month online courses, with students working through the modules at their own pace. There is a short assessment at the end of each module and on successful completion of the course students will receive a certificate and badge.
Sarah Endersby, ISFM’s Veterinary Development Manager, said: "We are very excited to offer cat friendly training for individuals. The courses are suitable for all members of the practice team, and you do not have to work in an accredited Cat Friendly Clinic to study with us, meaning that there is something for everyone."
For more information and to sign up, visit https://icatcare.org/cat-friendly-courses.
The research is being conducted by Sarah Mansell under the supervision of Dr. Malgorzata Behnke. They say this parasite hasn't been studied in depth in the UK since the 1970's, because the symptoms can be controlled by routine worming measures. However, as the industry moves away from routine worming as a measure of reducing the risk of parasites developing resistances to treatments, a condition such as this which is now considered to be quite rare in the UK can start to re-emerge.
Sarah is asking vets to fill out a short questionnaire to assess awareness of Onchocerca Cervicalis in veterinary practices. The survey includes specific questions about the parasite as well as questions about cases of unresponsive skin conditions because a similarity in symptoms can lead to misdiagnoses that could, in fact, turn out to be Onchocerca Cervicalis.
Sarah said: "Hopefully the findings will raise awareness of this problem and help shape future research in this area."
She added: "I want to get vets thinking about this issue much more than perhaps they are at the moment."
To take part in the survey, visit: https://harper-adams.onlinesurveys.ac.uk/assessing-the-awareness-of-onchocerca-cervicalis-amongst-e-2
The exhibition comprises 22 photographs showing a range of subjects from across the UK and overseas, including cattle during a TB testing day on the island of Arran, a surprising find during surgery, a look down the microscope at feline myofiber disarray and a practical session of bee veterinary medicine.
The photographs were selected from around 1,000 that were submitted to the association's photo competitions by its members in 2016 and 2017.
The exhibition was officially opened today by Neil Parish MP, Chair of the Environment, Food and Rural Affairs Committee (EfraCom) and BVA Honorary Member, at an opening ceremony attended by parliamentarians as well as many of the veterinary surgeons whose photographs feature in the exhibition.
Neil said: "These photos show the diverse range of things that vets are involved in. What we respect from BVA is that we get good clear, evidence-based advice when we need it."
BVA member and Director of Cambridge Veterinary Group Lucy Crosby was commended for her snake intubation picture last year. She said: "The exhibition is a really exciting opportunity for vets to show that their skills extend beyond the operating room to the arts.
"I personally feel privileged to have my photo shown here. The veterinary profession and what we do is diverse and it's important to broadcast to the general public just how important the profession’s contribution is to the country."
BVA President, John Fishwick said: "It's an honour to have the opportunity to exhibit our members’ photographs in the Palace of Westminster. Vets work in practices across the UK, in government policy, public health and food safety, industry and technology, the armed forces, and beyond.
"As a profession, we play a significant role in many areas of personal and political life; an issue that EU exit has brought into sharp relief. With the political landscape shifting so rapidly, it’s apt that we’re showcasing vets’ work to parliamentarians to make sure it’s at the forefront of their minds as they return for the New Year."
The exhibition will be open daily until Thursday 11 January in the Upper Waiting Room of the House of Commons, an area open to Members of Parliament, Peers and visiting members of the public.
To view the photographs exhibited, and many others from BVA’s photo competitions, visit BVA’s Flickr account: www.flickr.com/photos/britishvets/albums/
Discospondylitis describes the infection of an intervertebral disc and its adjacent cartilaginous end plates and vertebral bodies.
It is commonly bacterial or fungal in origin.
The disease can be challenging to diagnose as signs are variable and sometimes vague.
For the research, neurology specialists retrospectively examined cases which presented at multiple referral sites that have furthered the understanding, clinical and imaging features of discospondylitis.
To date MRI has been the imaging modality of choice, with consistent CT imaging features of discospondylitis in dogs and cats not previously reported in detail.
However with the increased availability of CT in clinical practice, the research set out to examine CT features that could support a diagnosis of discospondylitis.
Discospondylitis in cats is uncommon, and very little research had been undertaken in this area. This research group therefore reported clinical presentation and imaging data about a population of cats, to support the future diagnosis of these cases.
During the three studies*, the researchers found that:
The studies
Unite and the British Veterinary Union (BVU) have written to the government asking for the Professional Standards Authority (PSA), which regulates such governing bodies as the General Medical Council, General Dental Council, and Nursing and Midwifery Council (NMC), to have 'scrutiny' of the RCVS.
In a letter to junior minister at the Department for Environment, Food and Rural Affairs, George Eustice, the BVU chair Dr Shams Mir cited the case of Munhuwepasi Chikosi struck off the register of veterinary surgeons by the RCVS in June 2013.
Dr Mir said that this case was "widely seen by the veterinary profession as blatant miscarriage of justice and many expressions of 'outrage' were published in the veterinary press and online.
"One popular online veterinary forum recorded over a thousand posts criticising and challenging various aspects of the decision."
The current statutory duties of the RCVS, established by Royal Charter in 1844, are determined by the Veterinary Surgeons Act (VSA) of 1966, which Unite says is now 'outdated.
Dr Mir said: "BVU petitions the government to extend the remit of the PSA to incorporate the RCVS to ensure appropriate overview and scrutiny.
"The RCVS proposed new Royal Charter could be exploited by the RCVS to give itself proxy powers to introduce incontestable new regulatory measures."
Unite has asked for an urgent meeting with Mr. Eustice.
Unite professional officer Jane Beach said: "Our initiative is designed to safeguard the interests of both the public, and practicing vets and veterinary nurses in the UK.
"Basically, the way that the RCVS is presently constituted means that it is both judge and jury in disciplinary matters. It sets the rules and hands down the judgements - and we believe that an extra layer of scrutiny needs to be introduced which we would like to be the PSA."
David, who is Head of Clinical Intelligence at Vets Now, came in eighth place with 1,756 votes in this year’s RCVS Council elections.
The place was originally offered to Dr Tom Witte, who came in seventh place. However, due to a change in personal circumstances, he decided not to accept.
Professor Stephen May, RCVS President, said: "The loss of such a young, talented and respected Council member as Sarah has been difficult to come to terms with and she is greatly missed by her fellow Council members and others amongst the profession.
"It is also important to recognise that the New Year will bring us fresh challenges and opportunities and we will face them best with a full complement of Council members. Therefore, I am delighted that David will be joining Council from January and is able to attend his first Council meeting, which will be held in committee, with us on Thursday 18 January.
"The circumstances under which David will be joining us have been extremely sad, but I am sure he will be an excellent addition to our team and I look forward to working with him."
More information about David Leicester, including his candidate biography and manifesto, can be found in the Council election booklet sent out earlier this year and available to download from www.rcvs.org.uk/publications. A video of David talking about what he would bring to RCVS Council can also be found on the College’s YouTube channel: www.youtube.com/rcvsvideos